⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
KNSA News
Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares
Form 8-K
sec.gov
KNSA
Kiniksa Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Portfolio Execution
globenewswire.com
KNSA
REGN
Form 8-K
sec.gov
KNSA
Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences
globenewswire.com
KNSA
Form 8-K
sec.gov
KNSA
Form 8-K
sec.gov
KNSA
Form 8-K
sec.gov
KNSA
Kiniksa Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Portfolio Execution
globenewswire.com
KNSA
Kiniksa Pharmaceuticals to Report First Quarter 2026 Financial Results on April 28, 2026
globenewswire.com
KNSA
Kiniksa Pharmaceuticals Launches Targeted Direct-To-Consumer TV Campaign for ARCALYST® (rilonacept) in Recurrent Pericarditis
globenewswire.com
KNSA
REGN